Mental Health Bill [ Lords ] (Second sitting)

Chris Bloore Excerpts

Committee stage
Tuesday 10th June 2025 Public Bill Committees

[The Chair]

I think everyone is in agreement.

[Chris Bloore (Redditch) (Lab)]

On a point of order, Ms Furniss. Could we have some clarity on what adjourning the Committee right now would mean? Several members of the Committee have not returned from the Division, and it would be good to know the implications if we adjourn now.

[Aphra Brandreth]

The Conservative members of the Committee all came back at 5.40 pm, when we were asked to return.

--- Later in debate ---

[Gregory Stafford]

On a point of order, Ms Furniss. I called for a Division on the Adjournment before several members of the Committee who are now in the room came back. What is your ruling on whether members who were not here when the Division was called will be allowed to vote?

[Chris Bloore]

With the greatest of respect to the hon. Member for Farnham and Bordon, I clearly asked my question before the Question was put. We therefore have not divided yet.

[The Chair]

You wanted to know what adjourning now would mean for the progress of the Bill, and it would mean that we have to restart where we finished, so Thursday could be a longer day.

Dementia Care

Chris Bloore Excerpts

Tuesday 3rd June 2025 Commons Chamber

[Chris Bloore (Redditch) (Lab)]

I thank the hon. Member for South Devon (Caroline Voaden) for securing this important debate, which shines vital light on an issue that affects so many families across this country, especially in my constituency of Redditch and the villages.

Over 900,000 people in the UK are currently living with dementia, and by 2040 that number is expected to rise to 1.6 million. However, the challenge is not just the growing number of people affected, but the poor support that many receive and the inequalities that persist in diagnosis and care. It is estimated that only about 65% of people aged 65 or over who are thought to have dementia actually have a recorded diagnosis, which means that far too many people are missing out on vital help early on. That is especially true in communities including ethnic minorities and in deprived areas.

I have been contacted by many families in Redditch who describe the distress of waiting months—sometimes years—for a diagnosis or clear guidance on what to do next. One particularly heartbreaking aspect is the many families who are forced to sell the home of a parent who no longer knows that they cannot return home. These homes often represent a lifetime of memories, yet families face that heartbreaking decision simply because the system does not provide adequate care options.

A particularly worrying fact cited by Age UK is that 19% of people it spoke to were concerned about accessing dementia services—they did not know where to turn or felt unable to get the support they needed. We also have to confront the huge variation in care home capacity across England’s integrated care board areas. In some parts of the country, care home availability simply cannot meet demand, limiting options for people with dementia and their families. This postcode lottery means that some people wait longer or must travel far from home for care, which is unacceptable.

The challenges faced by our NHS are also starkly evident in dementia care. Too many patients with dementia are caught up in the crisis of corridor care, where beds are not available and patients wait in hospital corridors for hours or even days. It is deeply distressing for patients and their families, and exacerbates the risk of deterioration. Such failures are a direct consequence of years of under-investment in our NHS, which has stretched resources to breaking point.

My own mother served in the NHS for 40 years. She witnessed at first hand both its strengths and its struggles. I know how deeply committed this Government are, just as the then Government were in the late 1990s, to rebuilding and reinvesting in our NHS. The recent commitments to increase funding and recruit more staff are steps in the right direction, but we must ensure that translates into real improvements in dementia care on the ground.

[Mark Sewards (Leeds South West and Morley) (Lab)]

My hon. Friend is making a powerful speech. One of my constituents has a grandma who waited a staggering 18 months for a dementia diagnosis. The family did not have the £3,000 required to get a private diagnosis. My hon. Friend mentioned the need to increase the resources available to the NHS and how committed this Government are, so will he join me in encouraging the Minister to direct resources not just to dementia care, but to dementia diagnosis, so people can get the diagnosis they need faster?

[Chris Bloore]

My hon. Friend’s intervention highlights inequalities throughout the country and reaffirms why the hon. Member for South Devon sought this debate. People who cannot access private care are put at a huge disadvantage, which is simply not acceptable, so I agree with my hon. Friend’s call to the Government.

We know that people with dementia are far more likely to have unplanned hospital admissions, which can cause distress and often worsen their condition. That shows why we urgently need better community care, and why hospital staff must have improved dementia training to provide the care that these patients deserve.

The economic cost of dementia to the UK is enormous; including healthcare, social care and the wider costs to society, it is estimated to be over £42 billion a year. The huge financial burden highlights the importance not only of investing in medical research but of improving support and care infrastructure.

Unpaid carers play a massive and often overlooked role. In fact, family members and friends provide the majority of care for people living with dementia. Women make up a disproportionate share of unpaid carers, balancing that demanding role alongside work and other responsibilities. Their contribution is invaluable but can come at a significant personal cost, including financial strain, mental and physical exhaustion, and social isolation.

Age UK has made it clear that the system is overstretched and underfunded. People in Redditch, and everywhere else, deserve consistent, high-quality care that respects their dignity no matter where they live.

[Matt Rodda (Reading Central) (Lab)]

My hon. Friend is making an excellent speech. In particular, I commend him for the way in which he has talked about the support that relatives often give as caregivers. Will he elaborate a little further on the points he made about the need for more resources to be focused on less advantaged communities? My own experience in representing a community that has some disadvantages is that people in those communities, particularly families from ethnic minority backgrounds, need far more support.

[Chris Bloore]

I completely agree. It is clear from the data that disadvantaged communities and those from ethnic minorities are not getting the targeted support that they need; I see that in my constituency, particularly in the Winyates district of Redditch. The data shows a very clear reason for further intervention.

Diagnosis is only the start. The Alzheimer’s Society calls for a minimum standard of good quality post-diagnosis support, but real faults remain. Too many people receive little or no clear information after diagnosis. They are left to navigate a confusing maze of services alone, with inconsistent follow-up and limited access to support groups or counselling. That gap leaves families isolated and unsure about managing symptoms or planning for the future, increasing stress and uncertainty during a profoundly difficult time.

Carers also bear an incredible burden. Families in Redditch tell me about exhaustion and isolation. We need better respite care, as the hon. Member for South Devon said, and better financial support and mental health services for carers. Too many of my residents rely on the voluntary sector for support in their communities; I particularly commend the Astwood Bank memory café for the work that it does.

We must improve the skills of those caring for people with dementia. The Alzheimer’s Society calls for mandatory, high-quality dementia training for all adult social care workers. Hospital staff need better access to dementia training too, because too many patients experience distress and delays because staff do not have the skills that they need.

Importantly, dementia must have parity of esteem with cancers in funding and Government prioritisation. Dementia affects millions and carries a massive societal and economic cost. It deserves the same urgent intention, investment and commitment that cancers receive so that research, care and support can improve in step.

While investing in research is important, we cannot forget the urgent need to improve care for those people living with dementia. Dementia care is a test of our values. I am sure that no one in this House believes that anyone should face this journey alone or without support. We should all be committed to building a fairer, more compassionate care system that delivers for all, including the people of Redditch and the villages.

Parkinson’s Disease

Chris Bloore Excerpts

Wednesday 21st May 2025 Westminster Hall

[The Minister for Care (Stephen Kinnock)]

It is a great pleasure to serve under your chairship, Mr Stuart.

I pay tribute to my hon. Friend the Member for Colne Valley (Paul Davies) for securing this important debate. He spoke with real passion and conviction, as did hon. Members from across the Chamber. I do not know whether we have a full house from Dorset, but we have the hon. Member for West Dorset (Edward Morello), my hon. Friend the Member for South Dorset (Lloyd Hatton) and the hon. Member for Mid Dorset and North Poole (Vikki Slade); it was great to hear their thoughts. We also heard from the hon. Member for Strangford (Jim Shannon), who spoke, as always, with great passion and conviction. This debate follows closely on the heels of the Backbench Business debate on Parkinson’s Awareness Month, which was led by my hon. Friend the Member for Dunfermline and Dollar (Graeme Downie). I thank the Members who have spoken in both debates.

I pay tribute to the invaluable work of NHS clinicians, charities and care workers who spend every single day improving the lives of people with Parkinson’s disease. I am particularly encouraged by the Parky charter, which is raising public and professional awareness about the needs of the Parkinson’s community and the importance of timely diagnosis, comprehensive care and dignity for all people with Parkinson’s. Organisations that fight for patients, such as Parkinson’s UK, are at the heart of our policies for the NHS, which is broken but not beaten. We look forward to working with them to fix the foundations of the NHS and to make it work for people with Parkinson’s in Colne Valley, throughout Yorkshire and across the country.

Parkinson’s disease can severely impact every aspect of a person’s daily life, as well as the lives of their family and unpaid carers. It can put people under immense strain, and they deserve additional support to help them live with the condition. Around 153,000 people live with Parkinson’s in the UK, and it is the fastest growing neurological condition in the world. About 16.5 million people in the UK, or one in six of the population, have a neurological condition, and 600,000 people are diagnosed with one each year. Together, neurological conditions cause around 140,000 deaths every year in the UK—one fifth of all deaths—and they are the leading cause of disability.

In 2019, the NHS spent just under £4.5 billion on neurological conditions and they cost the UK economy £96 billion, so tackling them presents a real opportunity not just for the Government’s health mission but for our growth mission. We must face the fact that patients are facing significant challenges, including not enough people in the places we need them, and delays to treatment and care, with long waiting times. We also listen to patients who tell us that they have experienced a lack of information and support.

We are acting to address those challenges, starting with our workforce. Parkinson’s nurses and neurologists are worth their weight in gold, and they are key to meeting patient demand. This summer, we will publish a refreshed long-term workforce plan, as a first step towards rebuilding our workforce over the next decade and treating patients on time again. We will ensure that the NHS has the right people, in the right places, with the right skills, to deliver the care that patients need when they need it. We will set out in black and white the numbers of doctors, nurses and other professionals who will be needed in five, 10 and 15 years’ time.

Turning to waiting lists, the NHS constitution sets out that patients should start consultant-led treatment within a maximum of 18 weeks from referral for non-urgent conditions. At the start of the year, my right hon. and learned Friend the Prime Minister announced our elective reform plan, which sets out our approach to hitting that target by the end of this Parliament. We have already surpassed our manifesto pledge to deliver an extra 2 million elective appointments, seven months ahead of the deadline; we are now on 3 million appointments and counting. Many of those were appointments for treating Parkinson’s.

I know that there may be some people with Parkinson’s watching the debate at home and shouting at their telly, “Well, I am still waiting for treatment.” Although waiting lists are coming down, and recently fell for six months in a row, they are still high. I completely understand why people who are still waiting feel frustrated. I say to them: we are throwing the proverbial kitchen sink at waiting lists, and we will not stop until you see and feel the results.

The NHS has begun some important initiatives to improve its neurology services, including the neuroscience transformation programme, the Getting it Right First Time initiative, a strengthened clinical reference group and the appointment of a national clinical director for neurology. The NHS is focusing on improving patient experiences, addressing the disparities in care and ensuring that patients are given their medicines on time. The neuroscience transformation programme is focusing on faster diagnoses, better co-ordinated care and improved access to specialist services.

At the at the recent Backbench Business debate—and, of course, in this debate—a number of hon. Members spoke about personal independence payment as an important way of helping people to cope with the extra living costs of a disability or health condition. I am sure all Members would agree that those who can work should work. However, I am happy to reassure colleagues that our “Pathways to Work” Green Paper will make sure that people with the most severe lifelong health conditions who cannot work will see their incomes protected. We are consulting on the Green Paper to hear how best we can support those impacted by our reforms.

We continue to encourage research, which is advancing our understanding of Parkinson’s at breakneck speed, through targeted funding, infrastructure support and collaboration. For example, the UK Dementia Research Institute, sponsored by this Government, is partnering with Parkinson’s UK to establish a new £10 million research centre. The NIHR is supporting research that has discovered that eye scans can detect Parkinson’s disease up to seven years before symptoms appear, which helps people to receive treatment earlier and prepare themselves as best they can.

Research also underpins the entire drug discovery and development process. Produodopa is a groundbreaking new treatment for Parkinson’s disease, particularly for patients with advanced disease and severe motor fluctuations. It is revolutionary because it provides a continuous 24-hour infusion of medication via a small pump, allowing more consistent symptom control. The NHS rolled it out in February last year. It has been shown to improve motor function and has proved its worth by significantly improving the quality of life for people with advanced Parkinson’s.

At the debate on 1 May, many Members emphasised the importance of staying active. Indeed, there is strong scientific evidence that being physically active can help people to lead a healthier and happier life. For example, exercise can reduce the risk of major illnesses and lowers the risk of early death by up to a third. Our social prescribing programme is a key component of the NHS’s universal personalised care and a way for GPs or local agencies to refer people to a social prescribing link worker. Those workers give people time, focusing on what matters to them and taking a holistic approach to people’s health and wellbeing. They connect people to community groups and statutory services for practical and emotional support.

Looking forward, we have committed to publishing a 10-year plan for health to shift the focus of our NHS from hospital to community, from analogue to digital and from treatment to prevention. In the meantime, we have taken steps towards those shifts through the home-based care pathway, which is providing comprehensive support and care for people with Parkinson’s in their own home, and through the NIHR project to test a non-invasive vibrational cueing system, helping people with Parkinson’s to maintain their walking as they go about their everyday lives.

[Chris Bloore (Redditch) (Lab)]

I congratulate my hon. Friend the Member for Colne Valley (Paul Davies) on securing the debate. I declare an interest as a member of the APPG on Parkinson’s, as the son of a sufferer of Parkinson’s, and as the grandson of someone who died suffering of Parkinson’s. We all agree that, while there are real challenges, we must secure a cure for Parkinson’s. Does the Minister agree that we owe a great debt of gratitude to the partners, spouses and community groups that do so much to support people suffering from Parkinson’s as they go through not only horrific mobility loss but the associated deep psychiatric problems?

[Stephen Kinnock]

My hon. Friend is absolutely right; our system could not survive without the amazing and heroic work of our unpaid carers. One of our Government’s actions that I am most proud of is the change to the carer’s allowance. We increased the number of hours for which a carer can work and still keep their carer’s allowance by raising the threshold from £151 to £196. I hope that is giving carers the flexibility that they need. Many carers want to work but it is immensely stressful for them to balance their working and caring responsibilities. I was very pleased that we could announce that change back in January, but my hon. Friend is absolutely right that there is a lot more that we can do. I am working with colleagues in DWP and the Department for Business and Trade to look at how we can do more as a Government for unpaid carers. My hon. Friend is absolutely right to pay tribute to them; they are the lifeblood of our care system.

The consultation on our 10-year plan received over 190,000 responses, giving people with Parkinson’s and other conditions a voice in the future of healthcare. I want to conclude this debate by quoting just one of those voices—that of Winston, a former St John Ambulance worker from Lewisham. He said:

“People don’t always see what’s happening to me, or what Parkinson’s looks like on me. They don’t see me early in the morning. They see me looking nice and managing the condition as best I can. But I have to deal with my own bubble sometimes, and it gets burst, and things go all over the place.”

I am pleased that Winston is doing fantastically well and now sharing tips with people on how to improve their public speaking abilities. His words will resonate with anyone who has a long-term condition. Stories like his should remind us why we need a health service that sees the whole person, not just the condition, to give patients the dignity, care and respect that they deserve.

I thank my hon. Friend the Member for Colne Valley again for securing this important debate, and I pay tribute to all Members for making it constructive and powerful. I look forward to working with Members on this matter.

Ambulance Response Times

Chris Bloore Excerpts

Thursday 6th March 2025 Westminster Hall

[Chris Bloore (Redditch) (Lab)]

It is a pleasure to serve under your chairmanship, Ms Jardine. I congratulate the hon. Member for Glastonbury and Somerton (Sarah Dyke) on securing today�s important debate.

I welcome the news that ambulance waiting times are slowly improving in my area of the west midlands, but I would like to raise an issue that has been brought to me by several of my constituents in very distressing circumstances: how long those ambulances are having to wait outside A&E departments.

An ambulance service needs hospital services that can support it, and my constituents deserve to know that if they need urgent healthcare, an ambulance will turn up quickly and be able to deliver them to the appropriate care as soon as possible. At the moment, that is simply not happening: 66.6% of ambulances at Worcestershire Royal hospital, which serves many of my constituents, were left waiting longer than 30 minutes in the first week of January 2025. Prior to that, in October, only 50% of people attending any of the trust�s A&E departments, including mine in Redditch, were treated, admitted, or discharged within four hours. That same month, 1,300 ambulance patients waited more than an hour outside. I would like to share what that means in reality for some of my constituents.

My constituent Connie�s mother was sat in the back of an ambulance for hours outside the Royal, waiting for space to go in. Once she was finally admitted, she was left in a chair in a corridor for even longer. Not only is that a distressing situation for the patient, but while she was unable to be admitted, that ambulance was forced to stay outside and not be redeployed to help others. I heard from another constituent, Elaine, who had to call an ambulance for her 80-year-old mother-in-law due to a serious hypoglycaemic event, and although the ambulance crew were prompt in their arrival, she spent seven hours in the back of an ambulance as the A&E was not in a position to take her. She then spent 48 hours in A&E and a further three weeks in hospital before she was discharged, having received excellent care, but it is those seven hours that still stay with her now.

At the Alexandra hospital in my constituency, there are no in-patient children�s beds, so very sick children have to be taken to Worcestershire by ambulance if they need to be admitted. The Minister knows all too well that I have raised this issue with her before. If these services were provided more locally, over more than one site, ambulances would be freed up to deal with truly urgent cases across Worcestershire. Our ambulance and hospital staff work tirelessly to help us stay safe and well, but they are being let down by a system that has been neglected for too long.

I will not make a party political point, but�let�s be honest�we pay for the service we get. As the son of someone who worked in the NHS for 40 years, I would say that for too long we have not been investing in our health and social care systems in this country. We must take action now to ensure that our hospitals are given the resources they need so that handovers from ambulances can take place quickly and safely, and patients can truly receive the care that they deserve.

Maternity Services

Chris Bloore Excerpts

Tuesday 25th February 2025 Westminster Hall

[Chris Bloore (Redditch) (Lab)]

I congratulate the hon. Member for Chichester (Jess Brown-Fuller) on securing today’s debate. My constituents are watching at home and she eloquently set out the challenges that face our maternity services and the health of women across the UK, so I thank her for doing that so well.

When people in Redditch elect their Members of Parliament, they do so with a clear mandate on maternity services and the future of the Alexandra hospital. It would be remiss of me not to thank the shadow spokesperson, the hon. Member for Hinckley and Bosworth (Dr Evans) who did a tour of service at our hospital in the earlier parts of his career—we thank him for that.

Our maternity services are famed for delivering one Harry Styles many years ago—[Interruption.] Yes, just the one Harry Styles. More seriously, in 2015 our maternity services were closed and relocated to Worcestershire Royal. That temporary relocation was made permanent in 2017. That is the only site delivering such services across our entire county. That means many of my residents are forced to travel to Worcester or Birmingham to get the services they need.

Although the hon. Member for Chichester was brave enough to share some of the stories that she has heard from her constituents, I am quite frankly not strong enough to retell some of the stories I have heard—of stillbirths and, frighteningly, of parents giving birth to their children on the roadside—in the way that they deserve. Since 2015, the initial promises to return those services to my constituency have been forgotten. Despite signatories totalling over 50,000 from the local community, no parameters for the return of such services have been discussed by the ICB.

I want safe services for my constituents, but although I am concerned by the current configuration of services, I am deeply concerned about the future of services in my constituency. Worcestershire Royal has significant constraints on growth. Worcestershire is set to deliver tens of thousands of new homes and huge population growth in the next 10 years, with pressures on services set to rise substantially. As this Government seek to rebuild and reconfigure our NHS, it is time for those services to meet the needs of the present and, most importantly, deliver the services of the future. I urge the Government to review the decisions taken on the centralisation of services that may have made sense in the past, but will not in the future.

[Mr Angus MacDonald (Inverness, Skye and West Ross-shire) (LD)]

I am proud to represent Inverness, Skye and West Ross-shire. My colleague, my hon. Friend the Member for Caithness, Sutherland and Easter Ross (Jamie Stone), could not be here, but, on the subject of centralisation, our nearest maternity hospital is in Inverness, which is four hours each way from parts of Sutherland, Argyll, and the Isle of Eigg—around Muck, which I am sure the hon. Member is, or should be, familiar with. I wonder whether the hon. Member could support our case that centralisation is becoming a real problem for expectant mothers, who suffer enormous complications because of distance, given that smaller regional hospitals are no longer providing maternity care?

[Chris Bloore]

I thank the hon. Gentleman for his intervention and I am sorry to hear about the level of problems that mothers face his constituency. The hon. Member for Chichester started the debate saying that this is about services for women at their most vulnerable, when they are giving birth. It is clear from the experiences of the hon. Gentleman’s constituents and mine that services are not meeting the needs of those women when they need them the most. That is the challenge that we should now take up.

I conclude by saying that, in the past, the reconfiguration of services has been based on a financial envelope and the challenges of staff shortages, and that has dictated many decisions, but now is the time, with the Darzi report and the eloquent speeches we have heard today, to build that service for the future. We should all strive to meet that challenge, even if that means making difficult financial decisions to invest in the long term, so that we can give women and families the support that they deserve.

[Sir Christopher Chope (in the Chair)]

There are three speakers, and we have five minutes to go.

Respiratory Health

Chris Bloore Excerpts

Thursday 14th November 2024 Westminster Hall

[Jim Shannon (Strangford) (DUP)]

I beg to move,

That this House has considered respiratory health.

It is a pleasure to serve under your chairship, Mr Rosindell. I look forward to hon. Members’ contributions to this important debate, and I thank the Backbench Business Committee for granting it. I was before the Committee a week ago on Tuesday with three requests, and I was well looked after. This is the first of my three debates; the second is on 28 November in the main Chamber, and I am waiting to hear when the third will be. I hope to get more in after that—I will keep at it.

I declare an interest: I chair the all-party parliamentary group for respiratory health, and it is an issue that has affected my family. I became very aware of respiratory health because of how it affected my son. Did I understand it all? Probably not, but I understood it better from interacting with him. He is now 34 years old and married with two children, but he still has issues with his respiratory health.

I am delighted to be able to raise the issue. I look forward to all the contributions, particularly the response from the Minister for Secondary Care. It is always a pleasure to see her in her place: it makes my day and everybody else’s, I am sure. I know that she has a deep interest in the subject, so I am pretty sure that we will be encouraged by what she tells us. I am also pleased to see the shadow Minister, the hon. Member for Hinckley and Bosworth (Dr Evans), in his place. He and I have discussed the matter on a couple of occasions this week: we focused on what we would love to see come out of the debate.

This debate is not about us as Members; it is about our constituents and those who contact us. It will be on behalf of all the people in this great nation of the United Kingdom of Great Britain and Northern Ireland. As chair of the APPG, I will cover issues around asthma, severe asthma, chronic obstructive pulmonary disease and silicosis. The APPG has been conducting an inquiry on silicosis in particular. We have had meetings, usually on Zoom, with at least 20 contributors; the hon. Member for Blaydon and Consett (Liz Twist) and I have attended those meetings regularly.

I will frame my comments around the latest initiatives and the current policy direction, but I first want to say a few thank yous. I am indebted to Sarah Sleet and her wonderful team at Asthma and Lung UK for their outstanding help and ongoing support. They have been enormously helpful to me and the APPG and, I suspect, to other Members present. I welcome their latest report, “A Mission for Lung Health”, which was launched on Tuesday. I was there, as were some Members who are here today and many others who unfortunately cannot be.

I met Dr Jonathan Fuld, the national clinical director for respiratory disease, for the first time to get his expert advice and counsel. I had always seen him on Zoom on a laptop, but on Tuesday I met him in real life: we were able to shake hands and say hello. My thanks also go to Dr Richard Russell of the British Thoracic Society for his insights and opinion, and I pay tribute to the ongoing work of our expert stakeholder groups, which comprise senior clinicians, industry professional bodies and other experts. Whenever we have that vast amount of knowledge, experience and input on a Zoom meeting, we learn quickly: I learned quickly what the issues were.

There have been some very welcome developments in respiratory health recently, including the development of a new guideline for asthma, which is due to be launched soon as a collaboration among the National Institute for Health and Care Excellence, the Scottish Intercollegiate Guidelines Network and the BTS. The seasonal flu and covid vaccination programme appears to have been well planned and is rolling out well this year. Great credit and thanks are due to NHS England for its great work. Back home, where this is a devolved matter, I got two injections in one day: one for covid in the left arm and the ordinary one for flu in the right. It was like a conveyor belt: people were getting it every couple of minutes. It really is wonderful to see how well things can work when things go in the right direction.

The battle with smoking-related respiratory illnesses continues. The Government’s plans on smoking cessation, including through the Tobacco and Vapes Bill, are welcome. I understand that the Bill’s Report stage is coming next week, or certainly the week after. We hope that it will have a big impact in more deprived areas and on outcomes. When we were doing our research, having meetings and doing an inquiry into the matter, it became clear that it was more of an issue in deprived areas and areas of disadvantage. I will say a wee bit more about that later.

I hope that this debate will help to highlight World COPD Day, which falls on 20 November. I am sure that the Minister is well aware of the headline figures on respiratory health in the UK. They are worrying. The reason why this debate is so important is that the evidential base tells us that things are not getting better. That is why I look to the Minister for some succour, support and easement of mind.

Respiratory disease is the third biggest killer in England. In the UK, 7.2 million people have asthma, while 3 million are affected by COPD. These are not just figures; they are people, and their families are affected as well. The UK has a higher death rate due to respiratory illness than the OECD average, and the highest death rate in Europe. My goodness! If that does not scare us, it should. Over the past 10 years, more than 12,000 people have died from asthma. All those deaths were preventable. That is another reason why we are having this debate: because if we can prevent deaths, we should. It is important to put this on the record.

[Chris Bloore (Redditch) (Lab)]

Thank you for your chairmanship, Mr Rosindell. As an asthma sufferer, I know that one of the key elements of ensuring that we get the care we need is an annual survey with a clinician or GP about how our symptoms are either deteriorating or improving. I know many asthma sufferers who are not getting that annual review with their doctor. Some are going years without any sort of review of the deterioration of their symptoms. Given the really concerning number of people who die in this country from asthma attacks, is it not time that we did more to ensure that people get the yearly reviews they really need?

[Jim Shannon]

The hon. Member is absolutely right. If there are deaths of people with asthma that are attributable to not getting regular examinations or appointments with doctors or consultants, that is an issue that must be addressed. I am quite sure that the Minister is taking notes and that her civil servants and her Parliamentary Private Secretary will ensure that information is contributed to the debate.

NHS waiting lists for respiratory care have risen by 263% over the past decade. Poorly controlled respiratory disease results in hospital admissions doubling during the winter period. COPD exacerbations are the second most common cause of emergency hospital admissions. These are worrying figures—as worrying as the issue to which the hon. Member for Redditch (Chris Bloore) refers. New research presented at the European Respiratory Society has shown that the biologics uptake for severe asthma is disastrously poor: the national median for patients in England with severe asthma between 2016 and 2023 is 16%. The uptake varied widely among integrated care boards: it was between 2% and 29% against a target of 50% to 60%. These are worrying figures that indicate an unfortunate trend that should concern us all.

The burden of respiratory disease falls disproportionately on the most deprived. Adults in the poorest 10% of the country are more than two and a half times more likely to have COPD than the most affluent. The 10% most deprived children are four times more likely to require emergency admission to hospital due to asthma than the least deprived. Those figures show a fall-down and a need to focus on those areas.

Lung conditions, especially asthma and COPD, cost the NHS £9.6 billion in direct costs this year and every year. That represents 3.4% of total NHS expenditure. Those conditions result in 12.7 million work days being lost every year. The stats indicate a massive problem that needs to be addressed. The illness and premature death associated with them causes reductions in productivity totalling some £4.2 billion a year, and the conditions have an overall impact of £13.8 billion on the English economy.

All these stats tell us that we have a major problem. I ask the Minister that the NHS prioritise the issue. I understand that it was prioritised by the previous Government, but that that was not acted on because of the election, so I ask respectfully that it be prioritised in our strategy for the time ahead. Improving respiratory outcomes will help to achieve the Government’s ambitions to improve the nation’s health, to halve the disparities in health outcomes, to eliminate waiting lists, to break the winter crisis cycle and to enable everyone to live well for longer.

I have a number of questions for the Minister; I think my staff have sent her a draft of my speech and the questions I will ask. Will she confirm that respiratory health will be a priority for the Government? That is my first big ask. The APPG strongly supports the Secretary of State’s three shifts, which were announced following the Darzi report. I very much welcome that report, and the Secretary of State has done extremely well: it was a difficult portfolio to take on, but he has shown that he has the ideas to take it forward strategically. I hope the Minister can provide an idea of how that will happen for those with respiratory health issues.

The Darzi report proposes a shift from analogue to digital. We certainly have to improve the system that is used for our data and for healthcare more broadly, as the Secretary of State has said in the Chamber; I was very encouraged when I heard him talking about that shift. The other two shifts proposed are from hospital to community and from treatment to prevention. Those three should be front and centre, and they all have an important part to play in improving outcomes. The Government are right to highlight the impact of inequalities and deprivation on health. We strongly support their plans to achieve that through the three shifts, with which they have set a strategic course.

The statistics are clear: we have to improve outcomes for the most vulnerable in society. Our No. 1 duty as elected representatives is to look out for our constituents, particularly those who are vulnerable—that is why we are elected representatives. Our duty is to look after those who are less well-off, those who are physically vulnerable, those who are disabled and those who have other issues in their life.

Mortality rates from respiratory disease are higher among disadvantaged groups and areas of social deprivation, higher exposure to air pollution, higher smoking rates, poor housing conditions and exposure to occupational hazards. That has to be a major focus for us all. The trial of neighbourhood health centres could offer a significant shift from hospital to the community; the Government are considering that, and it is a good step in the right direction. We hope that we will enable a better focus for diagnosis and treatment of respiratory health, which could help to reduce inequalities. As the burden of respiratory disease disproportionately affects the most deprived parts of this great country, winter pressures are higher in those areas, so the centres need to be able to match the local challenges. Will the Minister indicate how that will happen?

Part of the challenge relates to the provision of spirometry testing, which is an essential diagnostic tool for asthma and for COPD. Community diagnostic centres currently offer very few spirometry tests; some offer none at all. I ask the Minister to confirm that spirometry will be widely rolled out, especially in deprived areas where we need its use to be widespread in primary care. It would be extremely helpful if spirometry could receive sustainable funding to be equitably delivered. I welcome the Minister’s thoughts.

As the Minister will be aware, the national screening committee has recommended introducing a targeted lung cancer screening programme across the UK. However, the screening programme only explores the possibility of lung cancer; unfortunately, it does not focus on addressing incidental findings of undiagnosed COPD identified during the screening. Including those findings would enable neighbourhood centres to help deliver better care for COPD.

We are aware of some work being undertaken in Hull to roll incidental findings into potential COPD diagnoses. I ask the Minister and NHS England to look closely at the outcomes of that study, which I believe will give some direction on what needs to be done in the United Kingdom. We are deeply grateful to those in Hull who are working on COPD diagnosis.

The national screening committee’s guidance on COPD has not been reviewed since 2019. I ask the Minister whether there are any plans to revisit that and to bring it up to date. It is five years since it was done, and the figures indicate a worrying trend of more disease. We need to have that in place.

Overprescribing of SABA inhalers—short-acting beta agonists—remains a big problem. Guidelines would be of enormous help. I ask the Minister to ensure full support for the NHS to implement new guidelines.

The APPG has been looking at the impact of inequality for some time. We highlighted that at our COPD event in the House at the end of last year. It was a well-attended event with constructive comments. As we always do in the APPG, off the back of that, we are looking forward more strategically, with a number of asks. We intend to hold regional events to enable local clinicians to inform us what more needs to be done. There is nothing better than asking clinicians the best way forward. They know. They deal with patients daily, and we deal regularly with constituents, and that helps us to focus attention, specifically on prevention.

The number of asthma deaths is far too high. They are worryingly high, as the hon. Member for Redditch mentioned. It has to be a priority for us all to reduce deaths as quickly as possible and for that to be an integral marker in the 10-year plan. The Secretary of State is giving us a 10-year plan. Perhaps the Minister can tell us today where the asthma and respiratory health focus is in that 10-year plan. It needs to have that focus, and I hope we get that response from the Minister today.

We are 10 years on from the national review of asthma deaths report and very little has changed in terms of asthma outcomes. A recent study showed that people on lower incomes reported greater use of oral corticosteroids than people on higher incomes. These findings highlight that there may be an increase in OCS prescriptions for people with asthma and COPD in more deprived areas. The study results are similar to those reported in the 2019 survey by Asthma and Lung UK. I again urge the Minister to keep an eye on that study, to see what lessons we can learn. I know the Minister is committed to making things better and we support her in her quest to do so, but I believe there are many who have helpful contributions on how that can be done.

The APPG also welcomes improvements in inhaler technology, specifically the move to combination inhalers, which will ultimately eliminate the use of twin inhalers. That should benefit both asthma and COPD patients and will contribute to the NHS’s net zero targets. There are lots of things that have to be done. We all subscribe to the net zero targets—they need to be addressed—and this is a way of achieving two goals in one.

We welcome the Government’s commitment to increasing the NHS workforce. That is very good news as well. We will see how that looks in the workforce plan next year. I ask the Minister to ensure that with a significant increase in staffing levels in primary care, we will see an end to untrained staff undertaking annual asthma reviews. I do not want to be too critical—that is not in my nature —but when there is an anomaly we have to address, it has to be said.

The APPG warmly welcomes the promise of the outcomes of the 10-year plan, and we will submit our response to the consultation. To have any real impact on respiratory health, though, we believe the plan has to be disease specific and contain suitable outcome measures for respiratory health. Will the Minister confirm whether the plan will include disease-specific measures for respiratory health? Again, I ask the Minister to benchmark metrics at the start of the plan and to factor in regular outcome updates at three, seven and 10 years. If we do that at those points, we can chart the progress, or perhaps the lack of progress, and make improvements. The metrics could include fewer asthma deaths; reduced hospital admissions for asthma and COPD, especially winter admissions; prescription data; and reduced incidence of asthma and COPD in the most deprived areas. Interim data outcomes will enable us to determine whether the plan is on track to deliver the outcomes we all want to see.

The use of biologics is of particular concern to the APPG and features regularly in our meetings. I am sorry to say that figures on the use of biologics in England are simply dreadful. The national median by patients with severe asthma in England between 2016 and 2023 sat at 16%, and the uptake varied widely among ICBs at between 2% and 29% against an uptake expectation within the clinical community of 50% to 60%. It just does not seem to be working. Biologics treatment has been described by our clinical advisers as life-saving for severe asthma patients. There is both wide regional variation in access, and unacceptable delays to the start of treatment. Many patients who need urgent treatment have to wait years to get access to the services that will prescribe biologics to them. That is an inefficient use of NHS resource and means that the health of patients is deteriorating while they wait for the right treatment. I do not want to see that, hon. Members do not want to see that, and I know the Minister does not want to see that either.

We need more easily accessible severe asthma services. Again, I would be much obliged if the Minister could meet us to look at how we can provide better asthma care for those with the highest burden of disease. I hope that the NHS innovation and adoption strategy will put forward solutions to tackle low and variable uptake and the access to innovative treatments, such as severe asthma biologics. The APPG would like to see a funded transformation with the health innovation networks and clinical leadership on the implementation of NICE guidance on respiratory health at neighbourhood level and on the delivery of biologics.

We are being constructive—the Minister knows that I will always be constructive because I believe we need to move forward together and ask the questions. I note the Secretary of State’s recent remarks on data sharing and the call by Asthma and Lung UK for greater data sharing in its report, which urges the Government to

“Improve data collection and analysis across the care pathway to bring together primary and secondary data, and make high quality, publicly available data which will help ICSs target care where it is needed and ensure accountability”.

We fully support that, and I do not think there is anybody in this room who would not support that, because it is absolutely the way forward.

We are also looking closely at the recent increase in silicosis cases around the country, especially in relation to engineered stone. It is something that maybe not everybody is aware of, although I suspect those in this room are. There is a real threat that the rise in what are entirely preventable cases may add considerably to local health pressures. The Secretary of State has been clear that we need to address the waiting lists and take more action to prevent cases, and that is something I have suggested needs to be done as well. There are a number of recommendations in our silicosis report, and a key recommendation concerns wider data sharing between primary and secondary care.

The APPG will hold a roundtable in the new year to ensure a timely discussion to inform the 10-year plan. I ask the Minister if she would be most kind and put it in her diary and come along. We are not here to give the Minister a hard time, but to take her contribution and help us to move forward together. The Parliamentary Private Secretary, the hon. Member for Aylesbury (Laura Kyrke-Smith), is not nodding because she cannot do that for the Minister, but she is indicating—I will send over the date, if that is okay.

Since 2015, 250 to 300 patients have been diagnosed with CF each year. Despite medical advances in recent years, in 2022 the median age of death for those with CF was just 33. Wow—think about that.

The Cystic Fibrosis Trust has called for greater financial support for people with cystic fibrosis for a number of years. In 2023, a University of Bristol study reported that a typical family with cystic fibrosis loses £6,800 a year due to the extra costs of living with that condition. The CF Trust has multiple requests, including for the Government to explore additional innovative market-incentive options to encourage the industry and others to fund research and trials for new antibiotics because of current antibiotic resistance.

I believe we have seen a good and positive contribution to research and development, but we are probably at a cusp where a bit more investment and help would get us over the line. We need to prioritise diagnostics for antimicrobial-resistant infections to prevent further lung damage. The Trust’s final request is to implement an early warning alert system on pollution for people with respiratory conditions.

I am looking forward to hearing what others have to say. The fact of the matter is that we have an opportunity this time because we have a Government who are spending £22 billion on the NHS. That is a massive amount of money. Every person in this great United Kingdom recognises what that means. It is the time to get it right. The Secretary of State has indicated that he is of that mind, and I know the Minister is also of that mind, so we have an opportunity to make effective change to the lives of people throughout this great United Kingdom of Great Britain and Northern Ireland. Some of the £22 billion will come to us in Northern Ireland through the Barnett consequentials, which is good news as well. It means that everybody gains across this great nation.

I believe now is the time to act. We in the APPG want to do all in our power to inform, support and guide the Minister and her Department in effecting change and improving quality of life for those with respiratory health issues.

[Adam Jogee (Newcastle-under-Lyme) (Lab)]

I start by joining the tributes to His Majesty the King on behalf of my constituents in Newcastle-under-Lyme as he marks his birthday today. It is excellent to see my hon. Friend the Minister in her position. I think it is the first time I have had a chance to speak when she has been on the Front Bench. It is very good to see her. I am also pleased to see that the shadow Minister’s brace has gone—evidence of the wonder of our national health service.

I am grateful for the opportunity to speak in this debate. I congratulate the hon. Member for Strangford (Jim Shannon) on leading it and on his opening remarks. He clearly enjoyed the lack of time limit, and probably the typo in the Order Paper that said that the debate would last for three hours. I thank him for his contribution. I should declare an interest: my wife is a deputy sister in an intensive care unit. I remain in full admiration of her and all her colleagues who work in our national health service on a daily basis.

My constituency is in the middle of our country, and air quality is one of the most important issues experienced by my constituents and one of the most frequently raised with me. It was with that in mind that I was delighted to host the Asthma and Lung UK reception in Parliament this Tuesday, where it launched its new report, “A Mission for Lung Health”. I encourage all colleagues present, all Members across the House and all those watching at home to read that report.

Air quality and respiratory health are some of the most important issues experienced by my constituents. The hon. Member for Strangford highlighted the fact that respiratory conditions are the third biggest killer in the United Kingdom, and one in five of us will be diagnosed with a lung condition in our lifetime. Colleagues will have heard me talk about the disgraceful Walleys Quarry landfill site in my constituency. For far too long, the operators have got away with doing whatever they want and leaving our town smothered by the most horrendous levels of hydrogen sulphide emitting from the site.

The levels of hydrogen sulphide have had an undeniable impact on the respiratory health of my constituents. I came down to London on Monday and will be heading back to my constituency shortly. I have had many reports from constituents back home that the levels have been horrendous this week. For us in Newcastle-under-Lyme, the fight for clean air is personal and it is constant. As I have the opportunity of the Floor, I make it clear again and reiterate to the Environment Agency, if it is listening: we need it to issue a closure notice with immediate effect to Walleys Quarry Ltd. We need to cap the site and restore it safely and swiftly.

[Chris Bloore]

rose—

[Adam Jogee]

I will happily give way to my hon. Friend from the west midlands.

[Chris Bloore]

Yes, the west midlands posse is here. I pay tribute to my hon. Friend for his work to draw attention to the disgraceful scenes at Walleys Quarry. We are having a conversation about the health of the nation, in particular air quality and the impact on respiratory health, and there is no doubt in my mind that the years of lack of action on that site have had an impact on people’s health. That cannot be allowed to continue.

[Adam Jogee]

We are on the way to getting my constituents the justice they deserve. I thank my hon. Friend for his support for our efforts, which have been led by many of my brilliant constituents, Dr Mick Salt, Lee Bernadette Walford, Simmo Burgess, Sheelagh Casey-Hulme and many others, who have been fighting hard. I could list many people. They did not all necessarily vote for me, but they have played an important role in helping to clean our air and save lives.

In recent weeks, there has been a pretty furious rush on behalf of the borough council and an increase in demands placed on the new Government. That is all well and good, but as far as I can see, little representation seems to have been made by the borough council to the previous Government, or indeed to Staffordshire county council. The only theme among all three of those institutions is that they are led by politicians of the same party. My message to my constituents is that change has come, and I am determined to ensure that that change delivers.

I hope that, after the profit-over-people approach of the operators at Walleys Quarry, we do not see that politics over people has prevented the site being closed and the respiratory health of my constituents being protected and enhanced. I will be grateful for an update from the Minister on what cross-departmental work has taken place in Government on such issues.

Access to diagnostic testing for respiratory conditions is in dire need of reform, and the example and experiences of my constituents prove that well. Access to spirometry testing for lung conditions, in particular since the covid-19 pandemic, has been a slow and painful process for too many people across the country. It is estimated that in our United Kingdom, more than 600,000 people live with undiagnosed COPD; the hon. Member for Strangford touched on that.

Even when restrictive respiratory conditions are suspected or diagnosed, people are waiting far too long for care. The latest NHS data shows that in August almost 5,000 people in Staffordshire—4,963, to be exact—were waiting beyond the national target of 18 weeks to be seen by a respiratory doctor. That is a little more than 50% of all patients referred for treatment. Although that is higher than the national average, it is sadly not an uncommon figure. It needs to change.

When patients are diagnosed with a respiratory condition, the quality of care they receive often does not meet the standards set by NICE. Asthma and Lung UK, to which I pay tribute for all its work, has found that 70% of those living with asthma are not receiving all three aspects of basic care, and that the care received by more than 90% of those with COPD does not meet the five fundamentals required by NICE.

People living with undiagnosed and poorly managed lung conditions are more susceptible to environmental factors such as air pollution, wintry weather and poor-quality housing, all of which, sadly, are applicable to the communities and people who live in the areas surrounding Walleys Quarry in Newcastle-under-Lyme. I would be grateful if the Minister took some time today—I am happy to talk at another time, too—to discuss strengthening the powers and scope of the UK Health Security Agency, because although it has an important role to play, most of that role is currently advisory.

As colleagues have highlighted—the hon. Member for Strangford certainly did—lung conditions are more strongly associated with deprivation than any other major health condition. Sadly, the result of these combined factors is clear and, as the hon. Member noted, respiratory conditions are the largest driver of A&E admissions each winter. Thousands of people living with undiagnosed and poorly managed respiratory conditions end up in A&E, adding even more strain to a national health service that is already under strain.

Last year, across the Staffordshire and Stoke-on-Trent integrated care board, 3,765 people were admitted to hospital in an emergency due to a lung condition. Yesterday, my right hon. Friend the Secretary of State for Health and Social Care reiterated this new Labour Government’s ambition to reform our national health service, but it is clear that that will not be achieved without prioritising respiratory health and care. That is entirely in line with the shifting focuses: from treatment to prevention, which has my full support; and from hospital to community care, where most respiratory care happens anyway. The Department should introduce a recovery fund of over £40 million over two years to increase the availability of testing. I know that is a big ask and I understand the financial pressures, but it would result in savings of £80 million for the national health service in reduced exacerbations, as well as a reduction of 85,474 hospital bed days.

Lastly, I want to touch on the link between waste crime and respiratory health. This morning, I received an email from Councillor Robert Bettley-Smith, the chair of Betley parish council in Newcastle-under-Lyme. Although he is in a different party from mine, I appreciate the spirit in which he works with me as we seek to serve the people who elected us. Councillor Bettley-Smith noted the continuing activity on the land at Doddlespool Hall farm in my constituency. I will not go into all the detail, but the link between waste crime and the disposal of waste generally has a huge impact on respiratory health. Councillor Bettley-Smith noted that, apart from the waste issue, there appears to be evidence, based on smoke and smell, that tyres or similar materials are being burned, and have been burned in the last week or so. The failures to regulate the waste sector under the previous Government must be put right by this new one, and I look forward to working with Ministers across Government to do exactly that.

There is a financial issue here, an environmental one and of course a health one too. I urge the excellent Minister to ensure that respiratory health is prioritised in the forthcoming 10-year plan for our beloved national health service and, importantly, in the upcoming review of the long-term workforce plan. I am grateful to the hon. Member for Strangford for introducing this debate, and I look forward to working with him, with the Minister and with colleagues across the House on these issues in the months and years ahead.

NHS Dentistry: South-west

Chris Bloore Excerpts

Tuesday 12th November 2024 Westminster Hall

[Dr Opher]

Yes, but that is even more shocking, is it not?

There are also disincentives in the contract for dentists to take on new NHS patients. When we look into it, there are all sorts of other things. For example, a dentist cannot provide urgent NHS dentistry unless they have used up their quota of UDAs, which are issued to dentists at the start of the year. The whole system is crazy, which is why there has been such a massive saving. As we have heard, dentists are leaving the profession, and it is clear that we are not training enough. I accept what the hon. Member for South West Devon (Rebecca Smith) said about how dentists are trained and where they are likely to end up working, because that is incredibly important.

As to solutions, we must have prevention. Dentistry is exceptional because dental treatment is preventive in its own right, so as soon as NHS dentistry is stripped away, there are immediately problems. We also have to make sure that young people’s diet is better. Dentist Cerri Mellish and I have developed a project in our area. Cerri sees young pre-school children who are under five. She has a quick look in their gobs and if there are signs of decay, they are whipped out and the children are given treatment. If there are any other signs of problems, she can give them fluoride enamel. These types of innovative solutions are really important.

One thing that happened with the pandemic was that NHS dentists stopped registering new patients. The pandemic started in 2020, so almost all pre-school children are likely not to be registered with a dentist, which is a real disaster. We should remember that two thirds of general anaesthetics used for children are used for dental reasons, and a general anaesthetic is not without risk.

[Chris Bloore (Redditch) (Lab)]

I congratulate the hon. Member for Honiton and Sidmouth (Richard Foord) on securing this important debate. I apologise for being an interloper from the west midlands, but it such an important debate that I want to add some thoughts.

My hon. Friend has hit on an important point. As the father of a toddler, I struggle every day to ensure that he brushes his teeth. The gap in the number of registrations since covid is creating a generation of children who are not used to going to the dentist. We have to reverse that trend; otherwise, we will have huge problems as a society, having to treat teenagers and adults with severe dental problems who have never been to the dentist.

[Dr Opher]

That is absolutely true. Simple things such as dental brushing schemes, which we introduced in the Stroud area before the election, are essential. Those sorts of things are often laughed at, but they are probably the most important thing we do as a Government.

One other quick win relates to urgent care. The Gloucestershire ICB, particularly in the Stroud area, was able to pay more for the units of dental activity and allowed all NHS dentists to do urgent care. In that way, some of the £86 million that the hon. Member for Honiton and Sidmouth (Richard Foord) talked about was spent. We were able to quadruple the number of urgent appointments.

We can do that kind of work on a smaller scale, but I suggest that we need to do things step-wise. We must get the prevention in place and start doing urgent dental care, and when we have enough money we can do more. It is all very well talking about fantastic NHS dentistry, but we need the funding for it and we need the taxes to pay for it. As a Government, we are responsible for that. In the long term, we need to look to universal NHS dentistry in this country.

World Stroke Day

Chris Bloore Excerpts

Tuesday 29th October 2024 Commons Chamber

[Sarah Dyke]

I thank the hon. Member for the intervention. He makes a strong point.

Our health and social care services are likely failing the 14,159 registered stroke survivors in Somerset at some stage in the system, but there is reason to be optimistic. If the Government put stroke at the heart of our health and social care system, each and every part of the system will be stronger and deliver better outcomes for everyone—not just stroke survivors.

Leaving aside the human cost, there is also an economic cost, as strokes lead to an avoidable £1.6 billion annual loss of productivity. I recently spoke to Garry, who works in Somerset and had a stroke in his 30s. He told me that he could have been back to work after nine months if he had had access to life-after-stroke care. Instead, he spent five years recovering, during which time he had to rely on the benefits system. At the start of the debate, I said that stroke is preventable, treatable and recoverable. If that is true—I know that it is—why are people like Garry forced to waste years in the prime of their life learning how to recover from strokes themselves?

[Chris Bloore (Redditch) (Lab)]

The hon. Lady is making an important point. Our clinical profession does an incredible job of saving many people who suffer from a stroke, but the rehabilitation work that follows surviving a stroke—the ability to get back into work, build emotional confidence and rebuild relationships—is so important. As she was detailing, too many people who survive strokes have to wait for years to get on with their lives, including their work, friendships and relationships.

[Sarah Dyke]

I wholeheartedly agree, and that is exactly the point that I was making.

Research from the Stroke Association shows that the NHS faces £1,300 of additional pressure for each person like Garry who does not receive life-after-stroke care, due to avoidable secondary strokes and other health complications. It is an injustice for stroke survivors who are suffering longer than they need to, for the taxpayer who could be paying less, and for the friends and families who often have no choice but to become unpaid carers to support stroke survivors, as my mum did for my dad after he suffered a stroke.

Unpaid carers currently bear 62% of the cost of prevalent strokes, with the NHS and social care bearing only a distant 9% and 22% respectively. Unpaid carers do a remarkable, important and often invisible job, and the Government must ensure they have access to the support that they need, including paid carer’s leave and a statutory guarantee of regular respite breaks.

There are not many easy answers when it comes to stroke. Constituents across Glastonbury and Somerton have written to me almost every month since my re-election because they are concerned about the closure of Yeovil district hospital hyper-acute services. It is right that steps are being taken to address the fact that 60% of people who arrive at hospitals do not get into a stroke unit quickly enough, so services are being reconfigured to provide patients with cutting-edge care in Dorchester or Taunton.

By concentrating hyper-acute services, wards can process patients more quickly, which is so important when caring for patients suffering from a stroke. After critical care has been provided, patients will be moved back to services closer to their home, such as Yeovil, so that family and friends will be able to visit their loved ones there rather than in critical care further away. I can understand why people are scared of potentially having to travel further in an emergency when response times are so poor. In fact, with an average response time of 42 minutes and 50 seconds, people in Somerset wait longer for an ambulance than anywhere else in England. For every minute a stroke is left untreated, nearly 2 million brain cells die, so fast ambulance response times are necessary for getting stroke patients lifesaving, disability-reducing treatments in time.

This is especially important for those living in rural locations, such as Glastonbury and Somerton, who may need to travel further for treatment. Liberal Democrat analysis has revealed that waits for life-threatening calls are 45% longer in rural areas than in urban ones. The average handover time for a category 2 ambulance call in Somerset has risen to over an hour, despite the ongoing 18-minute target, which results in ambulance crew being able to see only two or three patients per shift. The Government could lower these ambulance response times by increasing the number of staffed hospital beds, and ensuring our social care system is resourced well enough to allow people to recover outside hospital. We know that a matter of minutes can make all the difference in emergencies, so it is heartbreaking that ambulance delays are worsening and stroke victims are being left for hours for help to arrive.

I am inspired by the stroke quality improvement for rehabilitation project, which has helped over half the stroke survivors who were previously being failed by services in Somerset. The pilot has ensured that survivors have access to personalised and face-to-face support to help them with behavioural changes and re-entering work. Despite its success in preventing secondary strokes, and thus saving the health and social care system a great deal of money, the pilot is unlikely to receive funding from April next year, and 250 patients in Somerset face the prospect of losing access to good-quality life-after-stroke support.

I am particularly worried about stroke survivors in Glastonbury and Somerton, and elsewhere in Somerset, who will instead have to rely on Yeovil district hospital if this happens, as Yeovil district hospital provides only the minimum level of occupational therapy, physiotherapy, and speech and language therapy a week to less than half as many patients as the national average. There is a future where we no longer need to have a World Stroke Day, and that is what I am looking for—a future without a World Stroke Day.

Innovations such as the use of artificial intelligence in diagnosis could revolutionise recovery prospects for stroke patients, and preventive programmes could limit the impact stroke has on working-age people. We saw stroke mortality halved in just 10 years when stroke was prioritised in 2000, so progress can be made. If we are to reach that future, though, we must start by ringfencing budgets to enable the NHS to adopt innovative digital tools, invest in new technologies and develop a digital strategy.

This Government have already begun to make some progress with the Darzi report, which showed that the NHS is on its knees after years of mismanagement by the Conservatives, but we must ensure that stroke remains a top priority in their health mission.